To include your compound in the COVID-19 Resource Center, submit it here.

Inhibition of HIV tat could allow patients to halt ART

A paper published in Cell Reports builds on evidence that suggests inhibiting HIV tat protein (HIV tat) could treat HIV by blocking viral transcription and rebound from latent viral reservoirs.

In 2015, a team from the Scripps Research Institute led by Susana Valente showed that inhibiting HIV

Read the full 461 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers